The pharmaceutical industry is undergoing a significant transformation, fueled by the integration of AI and data-driven technologies. These innovations hold the promise of revolutionizing everything from personalized medicine to drug discovery and patient engagement. However, amidst the excitement surrounding these advancements, leaders must be cautious of the risks posed by jumping into AI adoption without fully understanding its potential or limitations. In this interview, Vikas Mahajan, Head of Data and Analytics at Indegene, offers valuable insights on how pharmaceutical organizations can
